Triglyceride glucose index is a significant predictor of severe disturbance of consciousness and all-cause mortality in critical cerebrovascular disease patients.
Chen T, Qian Y, Deng X.
Cardiovasc Diabetol. 2023 Jun 29;22(1):156. doi: 10.1186/s12933-023-01893-6.
Association of glycemic variability with death and severe consciousness disturbance among critically ill patients with cerebrovascular disease: analysis of the MIMIC-IV database.
Cai W, Li Y, Guo K, Wu X, Chen C, Lin X.
Cardiovasc Diabetol. 2023 Nov 16;22(1):315. doi: 10.1186/s12933-023-02048-3.
The benefits of being present: mindfulness and its role in psychological well-being.
Brown KW, Ryan RM.
J Pers Soc Psychol. 2003 Apr;84(4):822-48. doi: 10.1037/0022-3514.84.4.822.
Sleep and Circadian Disturbance in Disorders of Consciousness: Current Methods and the Way towards Clinical Implementation.
Van der Lande GJM, Blume C, Annen J.
Semin Neurol. 2022 Jun;42(3):283-298. doi: 10.1055/a-1893-2785. Epub 2022 Jul 6.
Meta-Analysis of the Effects of Xingnaojing Injection on Consciousness Disturbance.
Wu L, Zhang H, Xing Y, Gao Y, Li Y, Ren X, Li J, Nie B, Zhu L, Shang H, Gao Y.
Medicine (Baltimore). 2016 Feb;95(7):e2875. doi: 10.1097/MD.0000000000002875.
Disturbance of consciousness after postpartum hemorrhage.
Tanitame K, Akagi C, Kamaki N.
Eur J Intern Med. 2020 Dec;82:114-115. doi: 10.1016/j.ejim.2020.09.016. Epub 2020 Sep 24.
Nasal myiasis in patients with disturbance of consciousness: A case report and literature review.
Kuo H, Meng X, Huang X, Wu A, Long L.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Dec 28;46(12):1442-1446. doi: 10.11817/j.issn.1672-7347.2021.210152.
Phenomenological aspects of consciousness--its disturbance in acute and chronic stages.
Ohta T.
Acta Neurochir Suppl. 2005;93:191-3. doi: 10.1007/3-211-27577-0_33.
[Differential Diagnosis and Management of Disturbance of Consciousness:Approach to Comatose Patients].
Kobata H.
No Shinkei Geka. 2023 Nov;51(6):1009-1020. doi: 10.11477/mf.1436204847.
[Hyperammonemia with Disturbance of Consciousness during 5-FU plus Nedaplatin Therapy for Esophageal Cancer-A Case Report].
Okada T, Hirakawa T, Morimoto J, Tanaka H, Miyamoto H, Tsujio G, Kurihara S, Matsutani S, Nagashima D, Hirata K, Iwauchi T, Yamagata S, Uchima Y, Takeuchi K.
Gan To Kagaku Ryoho. 2020 Dec;47(13):1839-1841.
